
Dasa cuts net loss by 80% to R$35 million, generates R$292 million in free cash flow
EBITDA rises 53% on a comparable basis as margins improve and expenses decline; adjusted net debt…

EBITDA rises 53% on a comparable basis as margins improve and expenses decline; adjusted net debt…

Deal returns control of hospital and clinic in Botafogo to Amil from joint venture with Dasa.

Healthcare group improves diagnostics and cash flow, though results remain affected by asset sales and accounting…

Transaction strengthens regional network and requires no shareholder vote.

Company responds to regulator after report on potential acquisitions

Swiss Medical buys Argentine labs as Dasa trims leverage

E-commerce giant takes first step into over-the-counter medicine sales, pending antitrust approval
Market data by TradingView. Informational only — not investment advice.